Animal models for abdominal aortic aneurysms: Where we are and where we need to go

Abstract

The mortality rate of patients with abdominal aortic aneurysm (AAA) after rupture is extremely high, and this disease has become an important disease endangering the health of the Chinese population. Methods used to model AAA include intraluminal pressurized elastase infusion, chronic infusion of angiotensin II (Ang II) via an osmotic pump, periarterial application of calcium chloride, vascular grafting, and gene modification. AAA models induced by elastase and Ang II are the two most widely used animal models. In the elastase-induced model, because intraluminal infusion is transient, with the cessation of initial stimulation, the aneurysm lesion tends to be stable and rarely ruptures. The model induced by Ang II infusion often presents with a typical aortic dissection with a false lumen, whereas clinical AAA patients do not necessarily have dissection. Currently, the treatment of AAA in clinical practice remains endovascular, and there is a lack of pharmacological therapy, which is also related to the fact that the pathogenic mechanism has not been fully elucidated. Smoking, old age, male sex, and hypertension are the main risk factors for AAA, but these risk factors have not been fully investigated in the current modeling methods, which may affect the clinical translational application of research results based on animal models. Therefore, this article reviews the most commonly used AAA modeling methods, comments on their applications and limitations, and provides a perspective on the development of novel animal models.

Keywords

abdominal aortic aneurysm / angiotensin II / animal model / hypertension / porcine pancreatic elastase / smoking

References

[1] Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018; 67: e2: 2-77.

[2] Writing Committee M, Isselbacher EM, Preventza O, et al. ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022; 2022(80): e223-e393.

[3] Gigli M, Stolfo D, Merlo M, Sinagra G, Taylor MRG, Mestroni L. Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine. Nat Rev Cardiol. 2024. https://doi.org/10.1038/s41569-024-01074-2.

[4] Karthikesalingam A, Holt PJ, Vidal-Diez A, et al. Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA. Lancet. 2014; 383: 963-969.

[5] Quintana RA, Taylor WR. Cellular mechanisms of aortic aneurysm formation. Circ Res. 2019; 124: 607-618.

[6] Sakalihasan N, Michel JB, Katsargyris A, et al. Abdominal aortic aneurysms. Nat Rev Dis Prim. 2018; 4: 34.

[7] Tian K, Xia C, Liu H, et al. Temporal and quantitative analysis of aortic immunopathologies in elastase-induced mouse abdominal aortic aneurysms. J Immunol Res. 2021; 2021: 6297332.

[8] Li M, Wei P, Li K, et al. The incidence rate and histological characteristics of intimal hyperplasia in elastase-induced experimental abdominal aortic aneurysms in mice. Animal Model Exp Med. 2024; 7: 388-395.

[9] Liu H, Tian K, Xia C, et al. Kunming mouse strain is less susceptible to elastase-induced abdominal aortic aneurysms. Animal Model Exp Med. 2022; 5: 72-80.

[10] Busch A, Bleichert S, Ibrahim N, et al. Translating mouse models of abdominal aortic aneurysm to the translational needs of vascular surgery. JVS Vasc Sci. 2021; 2: 219-234.

[11] Golledge J, Krishna SM, Wang Y. Mouse models for abdominal aortic aneurysm. Br J Pharmacol. 2022; 179: 792-810.

[12] Lysgaard Poulsen J, Stubbe J, Lindholt JS. Animal models used to explore abdominal aortic aneurysms: a systematic review. Eur J Vasc Endovasc Surg. 2016; 52: 487-499.

[13] Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004; 24: 429-434.

[14] Senemaud J, Caligiuri G, Etienne H, Delbosc S, Michel JB, Coscas R. Translational relevance and recent advances of animal models of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2017; 37: 401-410.

[15] Anidjar S, Salzmann JL, Gentric D, Lagneau P, Camilleri JP, Michel JB. Elastase-induced experimental aneurysms in rats. Circulation. 1990; 82: 973-981.

[16] Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000; 105: 1641-1649.

[17] Nchimi A, Courtois A, El Hachemi M, et al. Multimodality imaging assessment of the deleterious role of the intraluminal thrombus on the growth of abdominal aortic aneurysm in a rat model. Eur Radiol. 2016; 26: 2378-2386.

[18] Xue C, Zhao G, Zhao Y, Chen YE, Zhang J. Mouse abdominal aortic aneurysm model induced by perivascular application of elastase. J Vis Exp. 2022; 180. https://doi.org/10.3791/63608.

[19] Gueldner PH, Marini AX, Li B, et al. Mechanical and matrix effects of short and long-duration exposure to beta-aminopropionitrile in elastase-induced model abdominal aortic aneurysm in mice. JVS Vasc Sci. 2023; 4: 100098.

[20] Berman AG, Romary DJ, Kerr KE, et al. Experimental aortic aneurysm severity and growth depend on topical elastase concentration and lysyl oxidase inhibition. Sci Rep. 2022; 12: 99.

[21] Romary DJ, Berman AG, Goergen CJ. High-frequency murine ultrasound provides enhanced metrics of BAPN-induced AAA growth. Am J Physiol Heart Circ Physiol. 2019; 317: H981-H990.

[22] Lu G, Su G, Davis JP, et al. A novel chronic advanced stage abdominal aortic aneurysm murine model. J Vasc Surg. 2017; 66 e4: 232-242.e4.

[23] Lin YC, Chen QY, Xiao J, et al. Mouse abdominal aortic aneurysm model induced by periarterial incubation of papain. Lab Investig. 2023; 103: 100035.

[24] Wei P, Li K, Li M, et al. The C57BL/6 N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm. Front Cardiovasc Med. 2024; 11: 1462032.

[25] Wang Y, Krishna S, Golledge J. The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis. 2013; 226: 29-39.

[26] Chiou AC, Chiu B, Pearce WH. Murine aortic aneurysm produced by periarterial application of calcium chloride. J Surg Res. 2001; 99: 371-376.

[27] Sawada H, Lu HS, Cassis LA, Daugherty A. Twenty years of studying AngII (angiotensin II)-induced abdominal aortic pathologies in mice: continuing questions and challenges to provide insight into the human disease. Arterioscler Thromb Vasc Biol. 2022; 42: 277-288.

[28] Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000; 105: 1605-1612.

[29] Sawada H, Daugherty A, Lu HS. Expression of a PCSK9 gain-of-function mutation in C57BL/6J mice to facilitate angiotensin II-induced AAAs. Biomol Ther. 2022; 12: 12.

[30] Lu H, Howatt DA, Balakrishnan A, Graham MJ, Mullick AE, Daugherty A. Hypercholesterolemia induced by a PCSK9 gain-of-function mutation augments angiotensin II-induced abdominal aortic aneurysms in C57BL/6 mice-brief report. Arterioscler Thromb Vasc Biol. 2016; 36: 1753-1757.

[31] Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg. 1994; 19: 446-456.

[32] Allaire E, Muscatelli-Groux B, Guinault AM, et al. Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg. 2004; 239: 417-427.

[33] Zhang J, Cao Y, Ren R, et al. Medium-dose Formoterol attenuated abdominal aortic aneurysm induced by EPO via beta2AR/cAMP/SIRT1 pathway. Adv Sci (Weinh). 2024; 11: e2306232.

[34] Zhang M, Sui W, Cheng C, et al. Erythropoietin promotes abdominal aortic aneurysms in mice through angiogenesis and inflammatory infiltration. Sci Transl Med. 2021; 13: 13.

[35] Wang Y, Krishna S, Walker PJ, Norman P, Golledge J. Transforming growth factor-beta and abdominal aortic aneurysms. Cardiovasc Pathol. 2013; 22: 126-132.

[36] Ye P, Chen W, Wu J, et al. GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. J Clin Invest. 2013; 123: 2317-2331.

[37] van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet. 2011; 43: 121-126.

[38] Wang S, Zhang C, Zhang M, et al. Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med. 2012; 18: 902-910.

[39] Shiomi M. The history of the WHHL rabbit, an animal model of familial hypercholesterolemia (II)—contribution to the development and validation of the therapeutics for hypercholesterolemia and atherosclerosis. J Atheroscler Thromb. 2020; 27: 119-131.

[40] Wang Y, Bai L, Lin Y, et al. Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits. Lipids Health Dis. 2015; 14: 82.

[41] Yu Q, Tian K, Fatima N, Zhao S. Diabetic status aggravates atherosclerosis in aged ApoE(−/−) mice. Animal Model Exp Med. 2024; 7: 964-965.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.